Epidemiologic Situation

1
Epidemiologic Situation

• As of today the lab has confirmed 17 P1 cases in
  five governorates
• Alhudaidah (11)
• Sanaa City (2)
• Hadarmoat Sayeun (2)
• Hajjah (2)
• Taiz (1)
• The first isolate was sent to CDC for genomic
  sequencing
• It should be noted that the available data
  regarding the number of AFP cases particularly in
  Alhudaidah is incomplete as there is a
  discrepancy between the number of AFP cases at
  the governorate and the central unit. We hope by
  the next issue this discrepancy will be sorted
  out.

2
WHO response

• In addition to the support extended by WR and WHO
  Staff in Yemen
• Dr Wahdan SA(P) visited Yemen 24-27 April
• Fielding of six additional experts, two of them
  to guide the epidemiologic work and the other
  four to assist in the planning of the NID
• Dr Tangerman will visit Yemen for one week
  starting 29 April
• Arrangements were made to secure the required
  doses of monovalent OPV1, which is expected to be
  in Yemen by mid May 2005
• A letter was sent to neighboring countries
  alerting them about the current situation
• Close monitoring of the situation including the
  issuance of regular reports. The current report
  is the first of these reports.

3
Planned Activities

• Next round is planned on 30 May 1 June
• Efforts are under way to ensure that the
  forthcoming round is implemented with a very high
  quality.
• Changing the strategy to house to house.
• Ensuring proper microplanning, including training
  of the vaccinators and supervisors.
• Establishing a system of supervision and of
  monitoring of the implementation of the campaign,
  including independent monitoring